lovenox enoxaparin sodium 100mg/1ml injection syringe with automatic safety lock system
sanofi-aventis australia pty ltd - enoxaparin sodium -
lovenox enoxaparin sodium 80mg/0.8ml injection syringe with automatic safety lock system
sanofi-aventis australia pty ltd - enoxaparin sodium -
lovenox enoxaparin sodium 60mg/0.6ml injection syringe with automatic safety lock system
sanofi-aventis australia pty ltd - enoxaparin sodium -
lovenox enoxaparin sodium 40mg/0.4ml injection syringe with automatic safety lock system
sanofi-aventis australia pty ltd - enoxaparin sodium -
lovenox enoxaparin sodium 20mg/0.2ml injection syringe with automatic safety lock system
sanofi-aventis australia pty ltd - enoxaparin sodium -
teuro 15000 iu (150 mg)/1 ml inj. sol. i.v./s.c. pre-filled syr.
laboratorios farmaceuticos rovi s.a. - enoxaparin sodium 15000 - solution for injection in pre-filled syringe - 15000 iu (150 mg)/ml - enoxaparin sodium 150 mg - enoxaparin
enoxaparine becat 15000 iu (150 mg)/1 ml inj. sol. i.v./s.c. pre-filled syr.
laboratorios farmaceuticos rovi s.a. - enoxaparin sodium 15000 - solution for injection in pre-filled syringe - 15000 iu (150 mg)/1 ml - enoxaparin sodium 15000 iu/ml - enoxaparin
lovenox forte enoxaparin sodium 150mg/1ml injection syringe
sanofi-aventis australia pty ltd - enoxaparin sodium -
clexane forte enoxaparin sodium 120mg/0.8ml injection syringe
sanofi-aventis australia pty ltd - enoxaparin sodium, quantity: 120 mg - injection, solution - excipient ingredients: water for injections; nitrogen - prevention of thrombo-embolic disorders of venous origin in patients undergoing orthopaedic and general surgery. prophylaxis of venous thromboembolism in medical patients bedridden due to acute illness. prevention of thrombosis in extra-corporeal circulation during haemodialysis. treatment of established deep vein thrombosis. treatment of unstable angina and non-q-wave myocardial infarction, administered concurrently with aspirin. treatment of acute st-segment elevation myocardial infarction (stemi) as an adjunctive to thrombolytic treatment, including patients to be managed medically or with subsequent percutaneous coronary intervention (pci).
crusia-aft
aft pharmaceuticals ltd - enoxaparin sodium 100 mg/ml; - solution for injection - 100 mg/ml - active: enoxaparin sodium 100 mg/ml excipient: water for injection - treatment of venous thromboembolic disease.